BMX	Bone marrow X-linked kinase
BTK	Bruton’s tyrosine kinase
cGVHD	Chronic graft versus host disease
CLL	Chronic lymphocytic leukemia
CSC	Cancer stem cell
CTL	Cytotoxic T lymphocytes
DC	Dendritic cell
EGFR	Epidermal growth factor receptor
ER	Estrogene receptor
i.v.	Intravenously
IC50	Half-maximal inhibitory concentration
IFN	Interferon
IL	Interleukin
ITK	interleukin-2-inducible T-cell kinase
MDSC	Myeloid-derived suppressor cell
MeSH	Medical Subject Headings
MZL	Marginal zone lymphoma
NCI	National cancer institute
NSCLC	Non-small-cell lung cancer
ORR	Overall response rate
PARP	poly-ADP-ribose-polymerase
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
PR	Progesterone receptor
q2w	2-weekly, every 2 weeks
RLK	Redundant-resting lymphocyte kinase
SLL	Small lymphocytic lymphoma
TEC	Tec protein tyrosine kinase
TFK	TEC family kinase
TNBC	Triple-negative breast cancer
WM	Waldenstrom’s macroglobulinemia